As PharmaVOICE enters its 10th year, the basic premise on which we founded the publication, and the company, remains as true today as it did on that February afternoon back in 2001: there is a fundamental need to understand the life-sciences industry from a holistic perspective that cuts across industry silos and provides a horizontal overview of the myriad topics that affect a drug or biologic compound from molecule through market. There are hundreds, if not thousands, of intersecting points along the drug development continuum. To do our jobs effectively, we contend that it is imperative to understand what happens before, during (directly and tangentially), and certainly after one’s interaction with a drug…
Filed Under:
Research & Development
